Kinvestor
News
Markets
Earnings
Insider
Portfolio
Pricing
Get Started
APLS
Apellis Pharmaceuticals Inc
Biotechnology
+ Watchlist
View SEC Filings
Overview
Financials
Earnings
Insider
Ownership
Filings
News
Apellis Pharmaceuticals Inc (APLS) Earnings
Last reported
April 30, 2026
EPS estimate
-$0.36
EPS actual
—
Revenue est.
$208.3M
Revenue actual
—
Related:
APLS overview
·
APLS financials
·
APLS news